RARE
#1846
Ultragenyx Pharmaceutical Inc. - Common Stock
25.6 1 USD
-0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.48%
Monthly Change
+2.28%
6 month change
+13.62%
Year Change
-16.03%
Previous Close
26.2 6
Open
25.6 1
Low
25.6 1
High
25.6 1
Volume
120
Financials
- Market Capitalization 2.52 B
- Employee 1 371
- Founded 2010
- CEO Emil Kakkis
- Website www.ultragenyx.com
- Headquarter Delaware, United States
- FIGI BBG001RWPDW6
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.95
Price to sales ratio
3.37
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1810 |  SLS SELLAS Life Sciences Group, Inc. - Common Stock | 13.21 USD | -13.15% | -14.66% | +33.03% | +588.02% | 2.67 B USD | ||
| 1826 |  VRDN Viridian Therapeutics, Inc. - Common Stock | 23.08 USD | -3.35% | -5.22% | +18.06% | +2.81% | 2.61 B USD | ||
| 1851 |  BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 9.82 USD | -0.51% | +3.37% | +3.70% | +17.32% | 2.51 B USD | ||
| 1857 |  PGEN Precigen, Inc. - Common Stock | 6.95 USD | -3.34% | -2.80% | +29.18% | +54.79% | 2.49 B USD |
Frequently asked questions about Ultragenyx Pharmaceutical Inc.
What is the Ultragenyx Pharmaceutical Inc. stock price today?
The current price of Ultragenyx Pharmaceutical Inc. (RARE) is 25.61. Over the past 24 hours, the stock has changed by -2.48%. Follow the RARE chart for real-time price dynamics.
What is the stock ticker of Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. trades under the ticker RARE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Ultragenyx Pharmaceutical Inc. stock going up?
RARE has changed by -0.54% over the last week, +2.28% over the last month, and -16.03% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. currently has a market capitalization of 2.52 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Ultragenyx Pharmaceutical Inc. earnings last quarter?
Last quarter, Ultragenyx Pharmaceutical Inc. reported earnings of -0.9 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Ultragenyx Pharmaceutical Inc. revenue for the last quarter?
Ultragenyx Pharmaceutical Inc. reported quarterly revenue of 214 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Ultragenyx Pharmaceutical Inc. net income for the last quarter?
Ultragenyx Pharmaceutical Inc. reported net income of -92 M for the last quarter. The previous quarter showed -185 M, which means net income changed by +50.27%.
How many employees does Ultragenyx Pharmaceutical Inc. have?
As of the latest available data, Ultragenyx Pharmaceutical Inc. has 1 371 employees. Workforce size can provide additional context about the company's scale and operations.
What is Ultragenyx Pharmaceutical Inc. EBITDA?
Ultragenyx Pharmaceutical Inc. EBITDA is -33 M, and its EBITDA margin is -15.42%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Ultragenyx Pharmaceutical Inc. stock?
You can buy Ultragenyx Pharmaceutical Inc. (RARE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Ultragenyx Pharmaceutical Inc. stock?
Investing in Ultragenyx Pharmaceutical Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RARE chart and related analysis on metatrader.com as part of your research.